What is CaNCURE?

CaNCURE was created in 2015 to provide Northeastern University undergrads with experiential training in cancer nanomedicine.  Sixty-six trainees have already completed the program so far, and we expect to train another eighty-nine students in the next 5 years.
Our co-op students spend 6-months performing hands-on research in a NCI-funded research laboratory.   This research experience is supplemented with research and bio/nano innovation seminars, professional development activities, and opportunities to present research.
Our alumni have successfully found new co-op and jobs in cancer research, scholarships to medical school, and scholarships to graduate school.  58% of alumni are currently performing cancer research.

66

Trainees

33

Mentors

22

Publications

108

Presentations


Hear from our Alumni:

“The work that I am doing may one day assist in providing new ways of identifying and monitoring cancer.  This means that physicians could find cancer earlier and provide patients with better treatment options, tailored to their individual disease at that moment in time.  This would improve patient’s prognosis and quality of life, which is the most important thing in the world.”

Rachel Fontana, Biochemistry, ’16


Trainee Spotlight


Kaylie DeCosmo

Health Sciences, '20

Nanoparticle-aided radio-immunotherapy

Esteban Enrique

Biochemistry, '20

Assessing sufficiency of the Tip60/p400 complex in inducing transcription of Merkel Cell Polyomavirus Small T antigen target genes.

Ryan Pan

Health Sciences, '20

Featured Trainee Publication


Upcoming Events

Academic Research Spin-Offs

Friday, March 22, 2019

Vinit Nijhawan Interim Executive Director Massachusetts Technology Transfer Center, UMass

119 Snell Libary -- NEU, 3:25 PM


Mentor Spotlight


G Mike Makrigiorgos, Ph.D.

Professor of Radiation Oncology, HMS

We apply nanoparticle-based approaches for DNA molecular diagnostics, PCR-based detection of DNA alterations, as well as the enrichment and identification of cancer biomarkers from blood-circulating DNA/RNA. We also combine site-specific image-guided irradiation with nanoparticle based approaches for enhancing detection of circulating biomarkers via ‘liquid biopsy’.


Ralph Weissleder, M.D., Ph.D.

Professor of Radiology, HMS

Our lab aims to use novel imaging and sensing techniques to measure major protein and network hubs of interest in a quantitative and predictive manner. Students will combine advanced microscopic imaging with systemically injectable nanoparticle-based sensors to perform quantitative single cell analysis of cancers during drug treatments in vivo.


Trainee Spotlight


Sydney Formica

Health Sciences, '20

Expression of anti-apoptotic proteins in pancreatic cancers: A potential barrier to photodynamic killing

Jessica Munck

Behavioral Neuroscience, '20

Assessment of atherosclerotic changes following neoadjuvant therapy using ferumoxytol as contrast imaging agent

Ryan Pan

Health Sciences, '20


 Get Involved

Interested in learning how nanomedicine is used to detect and treat cancer? Want to get involved in developing new nanotechnologies for the clinic? We are looking to match undergrads at Northeastern University with leading Boston researchers and clinicians for a six-month, hands-on research experience.  If you are thinking about a career in cancer science, engineering, or medicine, come get involved in the world’s first undergraduate program in cancer nanomedicine!  We have 9 upcoming openings for the January – June 2019 co-op period.  We will be accepting applications starting in September 2018 via NUcareers.

Going on in the lab right now...